Amneal announced a voluntary, consumer level recall of three lots of sulfamethoxazole/trimethoprim tablets because the tablets may exhibit black spots on the tablet surface due to microbial contamination.
Classification Type: Class 1 Recall
Optum Clinical Services has sent a drug recall notification to potentially impacted members and providers. Below are the notification details.
|
Product
|
Sulfamethoxazole/Trimethoprim Tablets
|
|
Manufacturer
|
Amneal
|
|
Recall Identification date
|
06/03/2025
|
|
Affected NDCs
|
65162-271-10, 65162-271-50
|
|
Look back period
|
04/04/2025 – 06/03/2025
|
|
Target population for clinical mailing
|
All
|
|
Messaging type
|
Mailing: Members; Direct Message/Fax: Providers
|
|
Data release
|
SS00005114
|
|
Fulfillment due date for NCQA compliance
|
On or before: 06/23/2025
|
|
WHA impacted members
|
2 members
|
|
Date letters were mailed out
|
6/16/2025
|
Last review date: July 14, 2025